p27Kip1 is required to maintain proliferative quiescence in the adult cochlea and pituitary

Cell Cycle

Volumn 10, Issue 8, 2011, Pages 1237-1248

  Oesterle, Elizabeth C ^a   Chien, Wei Ming ^b   Campbell, Sean ^a   Nellimarla, Praveena ^b   Fero, Matthew L ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b USA   (United States)

Author keywords

Auditory; Cdk inhibitor; Cell cycle; Cochlea; p27; Pituitary; Proliferation

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1B; PROTEIN P27; RNA; TAMOXIFEN;

ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CYCLE; CELL DIVISION; CELL PROLIFERATION; CELL SURVIVAL; COCHLEA; CONTROLLED STUDY; GENE EXPRESSION; GENE MUTATION; GERM LINE; HYPOPHYSIS INTERMEDIATE LOBE; HYPOPHYSIS TUMOR; KNOCKOUT GENE; MOUSE; NEUROEPITHELIUM; NONHUMAN; PROTEIN EXPRESSION; TUMOR GROWTH;

ANIMALIA; MUS;

EID: 79954488910     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.10.8.15301     Document Type: Article

References (45)

1. Chen P, Segil N. p27(Kip1) links cell proliferation to morphogenesis in the developing organ of Corti. Development 1999; 126:1581-90. (Pubitemid 29204323)
2. Löwenheim H, Furness DN, Kil J, Zinn C, Gültig K, Fero ML, et al. Gene disruption of p27(Kip1) allows cell proliferation in the postnatal and adult organ of Corti. Proc Natl Acad Sci USA 1999; 96:4084-8. (Pubitemid 29169040)
3. Nakayama K, Ishida N, Shirane M, Inomata A, Inoue T, Shishido N, et al. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia and pituitary tumors. Cell 1996; 85:707-20.
4. Kiyokawa H, Kineman RD, Manova-Todorova KO, Soares VC, Hoffman ES, Ono M, et al. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell 1996; 85:721-32.
5. Fero ML, Rivkin M, Tasch M, Porter P, Carow CE, Firpo E, et al. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis and female sterility in p27(Kip1)-deficient mice. Cell 1996; 85:733-44.
6. Kanzaki S, Beyer LA, Swiderski DL, Izumikawa M, Stöver T, Kawamoto K, et al. p27(Kip1) deficiency causes organ of Corti pathology and hearing loss. Hear Res 2006; 214:28-36.
7. Kip1 transcription directs cell cycle exit during organ of Corti development. Development 2006; 133:2817-26.
8. Ruben RJ. Development of the inner ear of the mouse: A radioautographic study of terminal mitoses. Acta Otolaryngol 1967; 220:1-44.
9. Davis MD, Lichtensteiger W, Schlumpf M, Bruinink A. Early postnatal development of pituitary intermediate lobe control in the rat by dopamine neurons. Neuroendocrinology 1984; 39:1-12. (Pubitemid 14115127)
10. Yamaguchi H, Aiba A, Nakamura K, Nakao K, Sakagami H, Goto K, et al. Dopamine D2 receptor plays a critical role in cell proliferation and proopiomelanocortin expression in the pituitary. Genes Cells 1996; 1:253-68. (Pubitemid 126673122)
11. Sherr CJ, Roberts JM. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 1995; 9:1149-63.
12. Chen P, Zindy F, Abdala C, Liu F, Li X, Roussel MF, et al. Progressive hearing loss in mice lacking the cyclin-dependent kinase inhibitor Ink4d. Nat Cell Biol 2003; 5:422-6. (Pubitemid 36592264)
13. Laine H, Doetzlhofer A, Mantela J, Ylikoski J, Laiho M, Roussel MF, et al. p19(Ink4d) and p21(Cip1) collaborate to maintain the postmitotic state of auditory hair cells, their codeletion leading to DNA damage and p53-mediated apoptosis. J Neurosci 2007; 27:1434-44.
14. Franklin DS, Godfrey VL, Lee H, Kovalev GI, Schoonhoven R, Chen-Kiang S, et al. CDK inhibitors p18(INK4c) and p27(Kip1) mediate two separate pathways to collaboratively suppress pituitary tumorigenesis. Genes Dev 1998; 12:2899-911. (Pubitemid 28440148)
15. Franklin DS, Godfrey VL, O'Brien DA, Deng C, Xiong Y. Functional collaboration between different cyclin-dependent kinase inhibitors suppresses tumor growth with distinct tissue specificity. Mol Cell Biol 2000; 20:6147-58. (Pubitemid 30613062)
16. Kip1 distinguish pituitary progenitor cell cycle exit from cell cycle reentry of differentiated cells. Mol Cell Biol 2009; 29:1895-908.
17. Wu L, de Bruin A, Saavedra HI, Starovic M, Trimboli A, Yang Y, et al. Extra-embryonic function of Rb is essential for embryonic development and viability. Nature 2003; 421:942-7. (Pubitemid 36288025)
18. Yu Y, Weber T, Yamashita T, Liu Z, Valentine MB, Cox BC, et al. In vivo proliferation of postmitotic cochlear supporting cells by acute ablation of the retinoblastoma protein in neonatal mice. J Neurosci 2010; 30:5927-36.
19. Weber T, Corbett MK, Chow LM, Valentine MB, Baker SJ, Zuo J. Rapid cell cycle reentry and cell death after acute inactivation of the retinoblastoma gene product in postnatal cochlear hair cells. Proc Natl Acad Sci USA 2008; 105:781-5.
20. Huang M, Sage C, Tang Y, Lee SG, Petrillo M, Hinds PW, et al. Overlapping and distinct pRb pathways in the mammalian auditory and vestibular organs. Cell Cycle 2011; 10:337-51.
21. Chien WM, Garrison K, Caufield E, Orthel J, Dill J, Fero ML. Differential gene expression of p27Kip1 and Rb knockout pituitary tumors associated with altered growth and angiogenesis. Cell Cycle 2007; 6:750-7. (Pubitemid 46535688)
22. Vooijs M, van der Valk M, te Riele H, Berns A. Flp-mediated tissue-specific inactivation of the retinoblastoma tumor suppressor gene in the mouse. Oncogene 1998; 17:1-12.
23. Oesterle EC, Stone JS. Hair Cell Regeneration, Repair and Protection. In: Salvi RJ, Popper AN, Fay RR, Eds. Hair cell regeneration. New York, NY: Springer Verlag 2008; 141-97.
24. Stone JS, Cotanche DA. Hair cell regeneration in the avian auditory epithelium. Int J Dev Biol 2007; 51:633-47. (Pubitemid 350084415)
25. Kip1. Proc Natl Acad Sci USA 2006; 103:4122-7.
26. Hayashi S, McMahon AP. Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: A tool for temporally regulated gene activation/inactivation in the mouse. Dev Biol 2002; 244:305-18. (Pubitemid 34450645)
27. Novak A, Guo C, Yang W, Nagy A, Lobe CG. Z/EG, a double reporter mouse line that expresses enhanced green fluorescent protein upon Cre-mediated excision. Genesis 2000; 28:147-55.
28. Oesterle EC, Campbell S, Taylor RR, Forge A, Hume CR. Sox2 and Jagged1 expression in normal and drug-damaged adult mouse inner ear. J Assoc Res Otolaryngol 2008; 9:65-89.
29. Hasson T, Mooseker MS. Porcine myosin-VI: Characterization of a new mammalian unconventional myosin. J Cell Biol 1994; 127:425-40. (Pubitemid 24313731)
30. Hume CR, Bratt DL, Oesterle EC. Expression of LHX3 and SOX2 during mouse inner ear development. Gene Expr Patterns 2007; 7:798-807. (Pubitemid 47213899)
31. Teta M, Rankin MM, Long SY, Stein GM, Kushner JA. Growth and regeneration of adult beta cells does not involve specialized progenitors. Dev Cell 2007; 12:817-26. (Pubitemid 46667754)
32. Tracy K, Dibling BC, Spike BT, Knabb JR, Schumacker P, Macleod KF. BNIP3 is an RB/E2F target gene required for hypoxia-induced autophagy. Mol Cell Biol 2007; 27:6229-42. (Pubitemid 47326709)
33. Seo DW, Li H, Guedez L, Wingfield PT, Diaz T, Salloum R, et al. TIMP-2 mediated inhibition of angiogenesis: An MMP-independent mechanism. Cell 2003; 114:171-80. (Pubitemid 36936911)
34. Stetler-Stevenson WG, Seo DW. TIMP-2: An endogenous inhibitor of angiogenesis. Trends Mol Med 2005; 11:97-103. (Pubitemid 40348986)
35. Laine H, Sulg M, Kirjavainen A, Pirvola U. Cell cycle regulation in the inner ear sensory epithelia: Role of cyclin D1 and cyclin-dependent kinase inhibitors. Dev Biol 2010; 337:134-46.
36. Endo T, Nakagawa T, Lee JE, Dong Y, Kim TS, Iguchi F, et al. Alteration in expression of p27 in auditory epithelia and neurons of mice during degeneration. Neurosci Lett 2002; 334:173-6. (Pubitemid 35346852)
37. Lengner CJ. iPS cell technology in regenerative medicine. Ann NY Acad Sci 2010; 1192:38-44.
38. Kesser BW, Lalwani AK. Gene therapy and stem cell transplantation: Strategies for hearing restoration. Adv Otorhinolaryngol 2009; 66:64-86.
39. Ono K, Nakagawa T, Kojima K, Matsumoto M, Kawauchi T, Hoshino M, et al. Silencing p27 reverses post-mitotic state of supporting cells in neonatal mouse cochleae. Mol Cell Neurosci 2009; 42:391-8.
40. Kil J, Gu R, Fero M, Lynch ED. The Open Otorhinolaryngology. Journal 2011; In press.
41. Gary KA, Chronwall BM. The onset of dopaminergic innervation during ontogeny decreases melanotrope proliferation in the intermediate lobe of the rat pituitary. Int J Dev Neurosci 1992; 10:131-42.
42. Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans. Proc Natl Acad Sci USA 2006; 103:15558-63.
43. Carneiro C, Jiao MS, Hu M, Shaffer D, Park M, Pandolfi PP, et al. p27 deficiency desensitizes Rb-/- cells to signals that trigger apoptosis during pituitary tumor development. Oncogene 2003; 22:361-9. (Pubitemid 36194332)
44. Benson C, White J, De Bono J, O'Donnell A, Raynaud F, Cruickshank C, et al. A phase I trial of the selective oral cyclin-dependent kinase inhibitor seliciclib (CYC202; R-Roscovitine), administered twice daily for 7 days every 21 days. Br J Cancer 2007; 96:29-37. (Pubitemid 46094635)
45. Hahn O, Stadler W. Sorafenib. Curr Opin Oncol 2006; 18:615-21.